/
GENPF
$0.02+$0.00 (+7.09%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.04
5% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-0.08
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $420.0K | $137.4K | $0 | $0 | $0 | $12.3K | $4.1K | $0 |
| Cost of revenue | $327.2K | $183.1K | $361.6K | $536.6K | $564.2K | $9.1K | $2.8K | $1.1K |
| Gross profit | $92.7K | −$45.7K | −$361.6K | −$536.6K | −$564.2K | $3.3K | $1.3K | −$1.1K |
| Gross margin | 22.1% | -33.3% | — | — | — | 26.4% | 32.0% | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$26.1K | −$143.3K | −$715.7K | −$1.7M | −$1.0M | −$880.9K | −$241.0K | −$153.3K |
| EBITDA | −$23.9K | −$162.7K | −$317.7K | −$1.1M | −$434.3K | −$3.8M | $49.1K | −$152.1K |
| Net income | $134.1K | −$164.7K | −$718.7K | −$1.7M | −$1.1M | −$4.4M | −$73.2K | −$335.0K |
| Net margin | 31.9% | -119.9% | — | — | — | -35600.3% | -1806.9% | — |
| EPS (diluted) | 0.00 | -0.00 | -0.01 | -0.03 | -0.02 | -0.07 | -0.00 | -0.01 |
Annual figures · source: Financial Modeling Prep
Peer comparison
GENIX PHARMACEUTICALS CP
GENIX PHARMACEUTICALS CP
Held by traders on TradeandTell
No one on the platform currently holds GENPF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in GENPF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded GENPF yet.